Prof. Urs Fischer is the Director and Chairman of the Department of Neurology at the University Hospital Bern, Switzerland. Prof. Fischer studied in Bern, London, San Francisco and Lomé and performed a “Master of Science by Research in Clinical Neurology” at the stroke prevention research unit at the University of Oxford. From August 2021 to Mai 2024 he was chairing the Department of Neurology in Basel, Switzerland. He is the president of the Swiss Neurological Society and the president elect of the European Stroke Organisation
Urs Fischer is a clinician scientist, interested in stroke and brain health and he aims to answer clinical relevant questions with randomised controlled trials and prospective registries. He served as principal investigator for several international multicenter academic trials on the management of patients with ischaemic and haemorrhagic stroke, such as the SWIFT DIRECT (The Lancet, PMID: 35810756), ELAN (NEJM, PMID: 37222476) and SWITCH (The Lancet, PMID: 38761811) trials. He is the Co-PI of the DISTAL, TECNO and ICARUS trials and part of the steering committee of the ELASPE, EMINENT-ICH and DO IT trials.
Urs Fischer loves music and he is playing the cello in a quartet.
